Table 1 Patient characteristics of those who underwent Hartmann’s reversal

Age (years)

69.5 (SD 8.8)

61 (SD 12.6)

p = 0.05*

63.1 (SD 12.3)

Gender

 Female

3

16

p = 0.31

19 (40.4)

 Male

9

19

28 (59.6)

Smoking Status

 Non-smoker

4

17

p = 0.43

21 (44.7)

 Current Smoker

2

8

10 (21.3)

 Ex-Smoker

6

10

16 (34.0)

Diabetes

1/12

7/28

p = 0.65

8 (17.0)

Ischaemic Heart disease

1/12

2/33

p = 1.00

3 (6.4)

Respiratory disease

1/12

9/35

p = 0.41

10 (21.3)

Renal disease

2/12

0/35

p = 0.06

2 (4.3)

Previous malignancy

0/12

1/35

p = 1.00

1 (2.1)

Medications

 Steroid use

1/12

2/33

p = 1.00

3 (6.4)

 PPI use

3/12

7/28

p = 0.70

10 (21.3)

Alcohol Use

2/12

5/35

p = 1.00

7 (14.9)

Weight (kg)

83.4 (SD 13.0)

76.6 (SD 20.2)

p = 0.19

78.3 (SD 18.7)

BSA (m²)

2.00 (SD 0.18)

1.85 (SD 0.29)

p = 0.05*

1.89 (SD 0.28)

BMI (kg/m²)

27.4 (SD 3.2)

28.6 (SD 6.7)

p = 0.93

27 (IQR 23–33)

Initial Indication for HP

 Large bowel obstruction

26 (55.3)

   Malignancy

6/12

16/35

p = 0.79

22

   Diverticular Stricture

0/12

4/35

p = 0.56

4

 Perforated diverticular disease

6/12

13/35

p = 0.51

18 (38.3)

 Iatrogenic

3 (6.4)

   Colonoscopic perforation

0/12

2/35

p = 1.00

2

   Colonic Ischemia

0/12

1/35

p = 1.00

1